Xtant Medical Holdings, Inc.
XTNT
$0.54
-$0.01-1.47%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -95.64% | -63.15% | 6,020.69% | 101.83% | 36.99% |
| Total Depreciation and Amortization | 56.68% | -0.68% | 8.85% | -6.45% | 6.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.84% | 76.99% | -38.14% | 39.92% | -30.29% |
| Change in Net Operating Assets | 720.63% | 107.15% | -194.47% | -201.81% | 184.19% |
| Cash from Operations | 16.65% | 261.44% | -0.16% | 92.18% | 138.71% |
| Capital Expenditure | 8.14% | -17.49% | 69.27% | -77.23% | 68.06% |
| Sale of Property, Plant, and Equipment | -76.15% | 122.45% | 2.08% | -54.29% | 10.53% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.98% | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.02% | 1,576.03% | 72.27% | -101.59% | 71.78% |
| Total Debt Issued | -12.69% | -3.35% | 5.95% | -4.43% | -1.59% |
| Total Debt Repaid | 17.53% | -21.42% | 0.42% | 3.96% | -5.16% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 81.82% | -5.77% | -477.78% | 86.76% | 26.88% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 55.88% | -1,033.33% | 90.91% |
| Cash from Financing | 38.62% | -971.75% | 172.03% | -7.61% | -116.07% |
| Foreign Exchange rate Adjustments | 101.19% | 542.11% | -850.00% | 98.17% | -619.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.54% | 124.97% | 303.82% | 9.13% | -153.79% |